 Interferon activation latent natural killer cells alteration kinetics target cell lysis clinical implications oral precancerous lesions Reduced natural killer cell activity patients oral leukoplakia submucous fibrosis normal control subjects number target lymphocytes normal precancers Treatment effector cells interferon-alpha active killer cell activity change target binding lymphocyte counts finding precytotoxic cells interferon exist peripheral blood direct recruitment new cell population place addition target lysis kinetics interferon-activated killer cells tremendous lytic activation statistical kinetic analysis natural killer cell activity important effector system immunosurveillance tumors modulation interferon exciting clinical possibility control malignant transformation oral precancers